DAYLI Partners

ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials that closely resemble human tissues and 3D printing technology.

DAAN Biotherapeutics is a biopharmaceutical company focused on developing innovative treatments for cancer patients. The company specializes in research and development in the field of cancer therapies, employing a range of approaches such as cell therapies, antibodies, and small molecule inhibitors. DAAN Biotherapeutics is particularly dedicated to immune-oncology, utilizing anticancer immune cell therapies, including natural killer (NK) cells and T cell receptors. Through its independent research infrastructure, the company conducts clinical trials to explore various treatment strategies, aiming to create effective new drugs, particularly for lung cancer. By providing healthcare providers with advanced therapeutic options, DAAN Biotherapeutics seeks to improve outcomes for cancer patients.

Kanaph Therapeutics is a biotechnology company focused on developing next-generation therapeutics for oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company engages in drug development activities ranging from discovery to early-stage clinical trials. Its therapeutic platform includes bi-specific antibodies, Fc-fusions, and small molecules. In oncology, Kanaph Therapeutics develops drugs with enhanced immuno-stimulatory activity in the tumor microenvironment for efficient tumor eradication. For autoimmune diseases, the company's pipeline features bispecific Fc-fusions that inhibit the alternative complement pathway, angiogenesis, and downstream complement activation. The company serves both Korea and the United States.

Medipixel, Inc. is a South Korean MedTech startup founded in 2017, specializing in artificial intelligence-based diagnostic software and semi-autonomous robotic systems for lung cancer and cardiac interventions. The company is comprised of a team of AI experts in computer vision, deep learning, and reinforcement learning, collaborating with top healthcare professionals, including those at Seoul Asan Medical Center, to enhance disease diagnosis and surgical procedures. Medipixel offers three primary solutions for intervention surgeons: an AI-based diagnosis tool that assists in identifying lesions during coronary angiography, a guide and planning solution that visualizes coronary arteries to facilitate guidewire manipulation, and an automated navigation engine that directs robotic units through arteries with real-time commands. These innovations aim to improve surgical outcomes and patient safety by reducing reliance on contrast agents and enhancing the precision of interventions.

CELLemedy is a biotechnology company focused on developing next-generation therapeutic proteins that aim to replace conventional antibody treatments. Utilizing a proprietary platform, CELLemedy enhances antigen-binding capabilities, offering broader applications compared to traditional antibodies. The company is dedicated to advancing human health through innovative biopharmaceuticals that improve treatment outcomes across various medical conditions, including cancer. By specializing in cancer immunotherapy and smart nanomedicine, CELLemedy is committed to creating therapeutics that enhance patient care for those suffering from cancer, thereby contributing to the evolving landscape of immuno-oncology.

CURAUM Inc. is a South Korean company focused on developing and selling innovative oral care and sleep-related health care products. Founded in 2017 and headquartered in Yuseong, South Korea, with additional offices in Seoul, Incheon, and Newport Beach, California, CURAUM offers a range of devices aimed at enhancing oral hygiene and managing sleep disorders. Their product line includes the Clium Cleaner, designed specifically for cleaning and sterilizing dental devices; the Clium S-Guard, an omnidirectional device that addresses obstructive sleep apnea and snoring; and the Clium System, which provides personalized management for chronic sleep disorders through a home health care platform. CURAUM also employs technology to collect and analyze users' health data, enabling the monitoring of hygiene status and early diagnosis of potential health issues, thereby promoting healthier habits and preventive care.

Arum Therapeutics is a pharmaceutical company focused on discovering and developing innovative therapeutics for cancer and respiratory diseases. The company is engaged in creating novel anticancer agents designed to address drug resistance by utilizing a platform based on synthetic lethality targets related to DNA damage response mechanisms. Through its efforts, Arum Therapeutics aims to provide effective treatment options for patients, addressing unmet medical needs in the current landscape of cancer therapies.

Illimis Therapeutics is a biotech company focused on developing innovative treatments for neurodegenerative diseases, particularly Alzheimer's disease. Utilizing a chimeric fusion protein platform, the company aims to address the significant medical needs associated with degenerative brain conditions. By specializing in fusion protein technology, Illimis Therapeutics seeks to offer new therapeutic modalities that enhance patient care and improve outcomes in the healthcare industry.

Generate great Experiance is an IT company that develops IoT equipment for medical platform.

Phantomics is an artificial intelligence company focused on the development of software for the analysis and diagnosis of cardiac MRIs. The company aims to enhance diagnostic accuracy through the use of biomarkers derived from medical images. Its technology enables comprehensive analysis of these images and biomarkers, facilitating quantitative and precise disease diagnosis and prognosis prediction. By providing tools that simplify the interpretation of complex medical data, Phantomics supports medical professionals in making informed clinical decisions, ultimately improving patient outcomes in cardiac care.

Protium Science is a biopharmaceutical company focused on drug research and development, offering analytical and quality assurance services. The company specializes in developing drug substances and finished drugs, overseeing all aspects of chemistry, manufacturing, and controls (CMC). By creating production cell lines, Protium Science aims to provide patients with access to customized medicines, enhancing the therapeutic landscape through tailored pharmaceutical solutions.

Gencellmed is a biotechnology company focused on developing innovative cancer treatments using its proprietary platform technology for creating oncolytic viruses. The company specializes in engineering next-generation herpes simplex virus type 1 (oHSV-1) based therapies that selectively infect and destroy cancer cells while stimulating the body's immune response against tumors. Gencellmed aims to provide novel, effective treatment options for patients with unmet clinical needs in oncology.

K-Cell is a biotechnology company that offers cell storage services.

Nuvilab is a company that focuses on transforming the food industry through innovative technology aimed at enhancing environmental sustainability and personal well-being. Its core product, the Nuvilab AI Food Scanner, employs advanced instant food recognition technology to accurately identify food types and volumes. By leveraging big data, Nuvilab integrates various food-related information, including details about leftovers, user preferences, and optimized menu recommendations. This comprehensive approach allows the company to provide users with personalized nutritional reports and guidelines, promoting healthier dietary habits. Through its solutions, Nuvilab aims to facilitate a more informed and sustainable approach to food consumption.

HMC Networks Co., Ltd. is a South Korean company established in 2013, based in Seoul, that specializes in providing management, consulting, and investment services tailored for hospitals and clinics. The company operates CareNation, a caregiver matching platform designed to connect caregivers, guardians, and patients, leveraging extensive industry expertise. Additionally, HMC Networks has divisions focused on medical devices, food products, and personal and joint care services. By utilizing big data, HMC Networks aims to drive service innovation and address information imbalances within the medical sector.

MxT Biotech is a biotechnology company focused on developing innovative microfluidic platforms for cell engineering and immunotherapies. The company specializes in microfluid-based intracellular material delivery, offering gene-editing services and automated process equipment. MxT Biotech provides cell therapy products, including non-viral-based intracellular mass transfer platforms known as mecha operators. These platforms enable professionals to effectively deliver genes and nucleic acids into cells by creating openings in the cell and nuclear membranes through the flow generated in microtubules.

Cellaputics Bio is a biotechnology company that develops cell therapy for treating degenerative and intractable diseases.

Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a bispecific antibody platform technology known as AliCE, which maintains the structural integrity of the parental antibody, ensuring high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL, a unique library of human antibodies, which supports its research and development efforts. The company is recognized for its contributions to the global immuno-chemotherapeutic drug market and also offers contract research services, aiming to advance its position within the biotechnology sector.

DeepCardio is a company focused on developing artificial intelligence technology to enhance the diagnosis of heart movements. It specializes in creating systems that accurately diagnose paroxysmal atrial fibrillation, a type of irregular heartbeat. By employing advanced deep learning techniques, DeepCardio enables healthcare professionals to predict arrhythmias even in patients who are not currently experiencing symptoms. This innovative approach aims to improve patient outcomes through more timely and accurate diagnoses, thereby addressing a critical need in cardiovascular health management.

SeaWith is a biotechnology startup focused on creating cell-cultured steak derived from seaweed, specifically utilizing a low-iodine seaweed variant known as Yo.od. The company aims to provide a sustainable alternative to traditional meat production by developing clean meat in a laboratory setting. SeaWith employs its proprietary culture media, made from microalgae, to cultivate meat that retains the taste and texture of conventional meat while being more affordable due to the abundance of microalgae. By doing so, SeaWith addresses the ethical and environmental challenges associated with livestock farming, offering consumers a delicious and cost-effective protein source that aligns with growing demands for sustainable food options.

iN Therapeutics is a biotechnology company focused on developing novel therapies for patients with intractable neurological disorders. Its drug development platform concentrates on Nav1.7 non-narcotic analgesics, hearing loss treatments, and brain disease therapeutics, aiming to provide pharmaceutical and biotech industries access to innovative central nervous system disease drugs.

Kynogen is a biotechnology company focused on developing anticancer therapies aimed at improving treatment outcomes for cancer patients. The company specializes in immunotherapy and cancer metabolic drugs, allowing healthcare professionals to target various types of cancer effectively. Kynogen's approach enables the integration of its therapies with existing anticancer treatments, enhancing their efficacy while significantly reducing costs. Through its innovative solutions, Kynogen aims to contribute to the advancement of cancer care and improve the quality of life for patients battling this disease.

Space F is an application industry platform business company that researches and develops cell farming technology.

Opticho is a company that develops ultrasound microscopes intended to enhance preclinical and clinical research. It specializes in the commercialization of these advanced imaging devices, which combine ultrasound diagnostics with laser technology. Utilizing optical principles and photoacoustic effects, Opticho's microscopes effectively visualize blood vessels, particularly peripheral ones. This innovative approach aids researchers in diagnosing peripheral vascular diseases, thereby contributing significantly to medical research and diagnostic capabilities.

Ubix Therapeutics, Inc. is a research and development company based in Seoul, South Korea, focused on the development of anti-cancer drugs utilizing a proprietary proteolysis targeting chimera platform. The company employs advanced inhibitor technology that degrades specific target proteins within cells, aiming to enhance therapeutic efficacy for various cancers. By binding to proteins associated with disease, Ubix Therapeutics seeks to provide life-saving medications for patients, thereby supporting both patients and medical professionals in the fight against cancer.

Galux specializes in molecular design technology aimed at discovering and developing innovative drugs for incurable and rare diseases. The company employs an AI-based drug design platform that integrates principles from artificial intelligence, physics, and chemistry. This technology allows Galux to design a variety of biomolecules, ranging from small molecules to peptides and larger proteins. By focusing on attractive biological targets, Galux seeks to provide healthcare professionals with effective treatments for conditions that currently lack viable therapeutic options.

Lynk Solutec is a laboratory-based company specializing in the development of biomedical devices. The company focuses on creating innovative solutions aimed at enhancing patient treatment, including a nano-oil film coating that prevents the adhesion of blood, viruses, and bacteria. Among its notable products is an anti-fog and anti-blood endoscope cap, designed to maintain a clear field of view during procedures. Lynk Solutec emphasizes research and development to address challenges faced in the medical field, providing healthcare professionals with effective and practical tools that improve patient safety and treatment outcomes.

LaSemilla is an ag-tech company focused on addressing the food crisis exacerbated by the global climate crisis. The company offers a sustainable food production platform and specializes in the development of crops that are engineered to be more resilient to changing environmental conditions. Utilizing advanced biotechnology, LaSemilla aims to enhance food security by equipping agricultural firms with innovative solutions that respond effectively to the challenges posed by climate change.

GI Cell is a biotechnology company focused on the development of immune cell-based therapeutics aimed at addressing complex diseases. Utilizing innovative platform technology, the company specializes in screening and optimizing ancillary proteins for targeted immune cells, which are essential in treating conditions such as cancer and inflammatory disorders. Additionally, GI Cell is involved in the creation of multi-valent sub-unit vaccines for COVID-19, leveraging its expertise in ancillary protein engineering and deep understanding of immunology. This approach enables medical practitioners to provide effective treatments for patients facing challenging health issues.

Anterogen is a bio-venture company focused on the research and development of cell therapy products and orphan drugs utilizing adult stem cells. The company has developed several products, including Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. In addition to its product offerings, Anterogen provides cell banking services and analytical services, which encompass sample analysis for clinical studies. Through its innovative approach, Anterogen aims to advance therapeutic options in the field of regenerative medicine.

CasCure Therapeutics specializes in developing personalized chemotherapy solutions to combat cancer. The company leverages artificial intelligence algorithms and deep learning technology to enhance its pipeline devices, which include Platform C for precision cancer medicines and Platform H for anti-cancer drugs. By utilizing advanced technologies such as CRISPR, CasCure Therapeutics aims to provide medical professionals with innovative tools and treatments that facilitate more effective cancer care and improve patient outcomes.

Tcino Bioscience develops molecule anti-cancer drugs for cancer patients.

Mthera Pharma is a biopharmaceutical research and development company focused on creating innovative therapies for complex diseases. The company is working on a pre-clinical drug that aims to enhance the translation of cutting-edge scientific discoveries into effective precision medicine. Mthera Pharma's lead compounds are designed to address multiple targets, enabling healthcare professionals to better manage conditions such as Parkinson's disease and dementia. Through its dedication to advancing medical science, Mthera Pharma seeks to transform the treatment landscape for these challenging diseases.

Pantillogos is a biotech developing next-generation immuno-oncology drugs using immunology, rental and transfer of licenses.

GenEdit Inc., established in 2016 and headquartered in Berkeley, California, specializes in developing innovative genome editing tools. The company's core technology is CRISPR/Cas9, which enables precise therapeutic gene editing. GenEdit has further advanced this field by creating the NanoGalaxy™ platform, a proprietary non-viral delivery system that efficiently transports CRISPR/Cas9 to target tissues, overcoming previous delivery challenges. This platform systematically screens a library of nanoparticles to ensure safer and more effective delivery, making therapeutic gene editing easier, faster, and more accurate than traditional methods. GenEdit's ultimate goal is to facilitate the cure of previously incurable genetic diseases by providing physicians with powerful tools for gene therapy.

Tomocube Inc., founded in 2015 and headquartered in Daejeon, South Korea, specializes in the design and manufacture of advanced 3D optical microscopes. The company offers products such as the HT-1 and HT-2, which utilize holotomography to create detailed 3D images of biological samples, including red blood cells, sperm cells, and CAR-T cells. Unlike conventional microscopes that provide only 2D views, Tomocube's innovative technology allows researchers to observe living cells in real-time without the need for invasive sample preparation. By integrating deep learning-based image recognition, Tomocube's microscopes facilitate the dynamic observation of cells and tissues, thereby enhancing the understanding, diagnosis, and treatment of human diseases.

Space F is an application industry platform business company that researches and develops cell farming technology.

SeaWith is a biotechnology startup focused on creating cell-cultured steak derived from seaweed, specifically utilizing a low-iodine seaweed variant known as Yo.od. The company aims to provide a sustainable alternative to traditional meat production by developing clean meat in a laboratory setting. SeaWith employs its proprietary culture media, made from microalgae, to cultivate meat that retains the taste and texture of conventional meat while being more affordable due to the abundance of microalgae. By doing so, SeaWith addresses the ethical and environmental challenges associated with livestock farming, offering consumers a delicious and cost-effective protein source that aligns with growing demands for sustainable food options.

Cellaputics Bio is a biotechnology company that develops cell therapy for treating degenerative and intractable diseases.

GI Innovation is a South Korean bio-venture company dedicated to the research and development of innovative biologics aimed at addressing diseases such as cancer and inflammatory conditions. The company focuses on immuno-oncology and inflammation/immunology diseases, leveraging its proprietary GI-SMART platform technology. This platform is designed to enhance the development of multi-targeting fusion protein therapeutics, thereby increasing both quality and productivity in drug development. Through well-structured translational research, GI Innovation aims to create new protein-based drugs that can effectively treat various health challenges faced by patients globally.

Newracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.

iN Therapeutics is a biotechnology company focused on developing novel therapies for patients with intractable neurological disorders. Its drug development platform concentrates on Nav1.7 non-narcotic analgesics, hearing loss treatments, and brain disease therapeutics, aiming to provide pharmaceutical and biotech industries access to innovative central nervous system disease drugs.

PharmCADD is a developer of an advanced drug development platform that integrates artificial intelligence, molecular dynamics simulation, quantum calculations, and protein structure prediction algorithms to enhance the drug discovery process. The company's key products include Pharmulator, a comprehensive platform designed to streamline drug discovery through five essential modules, which encompass protein and RNA 3D structure prediction, drug generation, virtual screening, quantum calculations, and toxicity prediction. This multifaceted approach aims to identify and generate drug candidates with improved efficacy. Additionally, PharmCADD offers PharmVAC, a specialized vaccine development platform that assists users in designing, analyzing, and visualizing RNA sequences for vaccine candidates, thereby optimizing the development process. Through these innovative tools, PharmCADD addresses the complexities of drug design and aims to accelerate the identification of effective therapies.

Mthera Pharma is a biopharmaceutical research and development company focused on creating innovative therapies for complex diseases. The company is working on a pre-clinical drug that aims to enhance the translation of cutting-edge scientific discoveries into effective precision medicine. Mthera Pharma's lead compounds are designed to address multiple targets, enabling healthcare professionals to better manage conditions such as Parkinson's disease and dementia. Through its dedication to advancing medical science, Mthera Pharma seeks to transform the treatment landscape for these challenging diseases.

Master Meditech Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development of new pharmaceuticals through protein structure identification and medicinal chemistry. Established in 2019, the company focuses on leveraging advanced scientific techniques to discover innovative drug candidates, aiming to address various medical needs. With a commitment to enhancing therapeutic options, Master Meditech is positioned at the intersection of technology and healthcare, striving to contribute to advancements in the pharmaceutical industry.

Space F is an application industry platform business company that researches and develops cell farming technology.

Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.

Idience is a drug development company focused on creating and commercializing innovative treatments for cancer. The company specializes in developing potent inhibitors that disrupt the repair of DNA single-strand breaks, leading to increased double-stranded breaks, which can induce synthetic lethality in cancer cells. This approach allows for targeted therapy against multiple solid tumors, both as a standalone treatment and in combination with other anti-cancer agents. Additionally, Idience employs advanced artificial intelligence to enhance medical imaging by automatically detecting and classifying various disorders across multiple imaging modalities, providing structured reports that improve diagnostic accuracy. Through these initiatives, Idience aims to drive significant advancements in cancer treatment and patient care.

Primoris Therapeutics is a medical research and development center.

Elgen Therapeutics develops an anti-cancer therapy platform. The company's platform creates drugs based on a new epigenetic target and the discovery of a new E3 ligase ligand, allowing medical professionals to find treatment for cancer.

Vaxcell Bio Therapeutics is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The firm specializes in creating cell-based and protein-based immunotherapeutics aimed at enhancing the immune system's ability to fight cancer. By leveraging advanced biotechnological methods, Vaxcell Bio is dedicated to addressing unmet medical needs in oncology through its pipeline of anti-cancer drugs and other novel therapeutic solutions.

CURAUM Inc. is a South Korean company focused on developing and selling innovative oral care and sleep-related health care products. Founded in 2017 and headquartered in Yuseong, South Korea, with additional offices in Seoul, Incheon, and Newport Beach, California, CURAUM offers a range of devices aimed at enhancing oral hygiene and managing sleep disorders. Their product line includes the Clium Cleaner, designed specifically for cleaning and sterilizing dental devices; the Clium S-Guard, an omnidirectional device that addresses obstructive sleep apnea and snoring; and the Clium System, which provides personalized management for chronic sleep disorders through a home health care platform. CURAUM also employs technology to collect and analyze users' health data, enabling the monitoring of hygiene status and early diagnosis of potential health issues, thereby promoting healthier habits and preventive care.

JD Bioscience is a drug development company focused on creating medical research solutions for metabolic disorders. The company specializes in developing small-molecule therapeutics designed to address metabolic complications associated with hard-to-cure diseases. By employing a novel mechanism that efficiently inhibits biogenesis in peripheral white adipose tissues, JD Bioscience aims to provide effective treatment options for obesity and various metabolic diseases.

RevoSkectch is a molecular diagnostics company focused on developing digital PCR platform with unique spin partitioning technology. revoskectch is to provide the simplest and affordable digital PCR solutions to life science industry.

MirimGene is a biotechnology company focused on developing innovative drugs aimed at treating intractable infections and immune disorders. The company specializes in personalized precision medicine, targeting a novel endogenous immune activation factor network to create effective treatments for infectious diseases that currently have no available therapies and high mortality rates. By addressing intractable immune diseases resistant to existing medications, MirimGene enables healthcare providers to offer solutions for patients who have limited or no treatment options.

Paprika Care is a developer of a mobile application designed to assist health-conscious individuals in managing their medication. The application serves as a tracker, reminding users to take their medication on time while also allowing them to monitor their progress and gain insights about their prescriptions. Additionally, Paprika Care's platform enables families and healthcare professionals to remotely oversee the medication intake of their loved ones or patients, fostering better adherence to treatment plans. By combining functionality with user-friendly features, Paprika Care aims to enhance medication management and improve overall health outcomes.

PharmCADD is a developer of an advanced drug development platform that integrates artificial intelligence, molecular dynamics simulation, quantum calculations, and protein structure prediction algorithms to enhance the drug discovery process. The company's key products include Pharmulator, a comprehensive platform designed to streamline drug discovery through five essential modules, which encompass protein and RNA 3D structure prediction, drug generation, virtual screening, quantum calculations, and toxicity prediction. This multifaceted approach aims to identify and generate drug candidates with improved efficacy. Additionally, PharmCADD offers PharmVAC, a specialized vaccine development platform that assists users in designing, analyzing, and visualizing RNA sequences for vaccine candidates, thereby optimizing the development process. Through these innovative tools, PharmCADD addresses the complexities of drug design and aims to accelerate the identification of effective therapies.

ROKIT Healthcare specializes in the development and application of advanced 3D bioprinting technology. They offer custom hardware, software, and support services, focusing on the design and creation of personalized medical solutions. The company's core expertise lies in regenerating skin and cartilage organs using artificial intelligence and proprietary bio-fabrication techniques, aiming to improve patient outcomes through innovative surgical procedures.

AUTOTAC Bio is a drug development company focused on creating innovative therapeutics through its proprietary protein target decomposition technology. The company aims to address a range of medical challenges by developing treatments for various rare and incurable diseases, including cancers, degenerative brain diseases, amyloid diseases, autoimmunity, and viral infections such as coronavirus. By leveraging autophagy-based mechanisms, AUTOTAC Bio enables pharmaceutical companies to enhance patient health and improve treatment outcomes for conditions that currently lack effective therapies.

Mthera Pharma is a biopharmaceutical research and development company focused on creating innovative therapies for complex diseases. The company is working on a pre-clinical drug that aims to enhance the translation of cutting-edge scientific discoveries into effective precision medicine. Mthera Pharma's lead compounds are designed to address multiple targets, enabling healthcare professionals to better manage conditions such as Parkinson's disease and dementia. Through its dedication to advancing medical science, Mthera Pharma seeks to transform the treatment landscape for these challenging diseases.

AM Sciences is a drug development company focused on creating therapeutic compounds for the treatment of Hepatitis B and liver fibrosis. The company specializes in developing AMS-I series compounds that act as capsid formation inhibitors. These compounds have demonstrated the potential to significantly enhance the functional cure rates for individuals suffering from chronic Hepatitis B, thereby helping patients alleviate symptoms and prevent disease progression. Through its innovative research and development efforts, AM Sciences aims to provide effective treatments for those affected by these serious liver conditions.

CSK Inc. is a manufacturer specializing in products for the semiconductor and LCD industries, with operations in Asia, America, and globally. Founded in 1997 and headquartered in Yongin, South Korea, the company develops a range of solutions including plasma and wet scrubbers, thermal and wet scrubbers, and burn and wet combination scrubbers designed to purify harmful gases generated during semiconductor manufacturing. Additionally, CSK provides precursor delivery systems aimed at waste gas abatement. The company also serves the South Korean markets for display, solar, and LED technologies, positioning itself as a key supplier of exhaust management systems. As of August 2016, CSK operates as a subsidiary of Atlas Copco AB.

Huons Global Co is a holding and pharmaceutical company dedicated to providing medical solutions for human health. Established in 1965, the company has a long history of manufacturing high-quality finished products, including Korea's first local anesthetics and plastic ampoule injections. Huons Global operates through three primary divisions: pharmaceuticals, medical devices, and cosmetics. The pharmaceutical division focuses on the production of ethical drugs, while the medical devices division develops equipment for the safe preparation of platelet-poor plasma and platelet concentrate from blood samples. Additionally, the company offers a range of cosmetic products, including cleansers, creams, and sunscreens. With a commitment to stringent quality control and ongoing research and development, Huons Global exports its pharmaceutical products to approximately 30 countries across North and South America, Europe, Japan, Asia, and Africa.

Sugentech Incorporated is an in-vitro diagnostic company based in Daejeon, South Korea, specializing in personal point-of-care testing products and personalized diagnosis solutions. Founded in 2011, the company focuses on developing innovative healthcare technologies by integrating biotechnology, information technology, and nanotechnology. Sugentech's product offerings include laboratory tests such as immunoblot processors and molecular diagnostics systems, as well as self-diagnostic home testing kits. Their portfolio features tests for various analytes, including C-reactive protein, procalcitonin, and troponin I, along with personal care tests like digital ovulation and pregnancy tests. Formerly known as Accugen Healthcare, Sugentech changed its name in 2013 to reflect its commitment to pioneering advancements in health diagnostics.

Medipixel, Inc. is a South Korean MedTech startup founded in 2017, specializing in artificial intelligence-based diagnostic software and semi-autonomous robotic systems for lung cancer and cardiac interventions. The company is comprised of a team of AI experts in computer vision, deep learning, and reinforcement learning, collaborating with top healthcare professionals, including those at Seoul Asan Medical Center, to enhance disease diagnosis and surgical procedures. Medipixel offers three primary solutions for intervention surgeons: an AI-based diagnosis tool that assists in identifying lesions during coronary angiography, a guide and planning solution that visualizes coronary arteries to facilitate guidewire manipulation, and an automated navigation engine that directs robotic units through arteries with real-time commands. These innovations aim to improve surgical outcomes and patient safety by reducing reliance on contrast agents and enhancing the precision of interventions.

Curiox Biosystems Pte. Ltd. is a bioinstrumentation company that specializes in the development and commercialization of innovative assay platforms aimed at advancing the life sciences, drug discovery, and diagnostics. Established in 2007 and headquartered in Singapore, Curiox offers a range of products designed to enhance the efficiency and automation of bioassays, including DropArray microplates for miniaturized assays and Laminar Wash technology for automated cell processing. Its product lineup includes various washing stations, microplates, fluids, and accessories tailored for applications such as bead-based immunoassays, suspension cell assays, high-content assays, and iPS cell research. Leveraging expertise in surface chemistry and engineering, Curiox is committed to overcoming challenges in life science research through improved automation and reproducibility.

Alodokter is a digital health platform based in Indonesia that offers a comprehensive range of services aimed at enhancing patient care. The platform facilitates telemedicine services, allowing patients to connect with qualified doctors for consultations. In addition to this, Alodokter provides users with credible health information, supportive communities, and detailed reference materials covering various health topics. By enabling appointment booking and offering resources about illnesses, treatments, and healthy living, Alodokter empowers individuals to make informed health decisions, particularly in emergency situations. The platform is designed to improve accessibility to quality healthcare information and professional medical support for users across Indonesia.

MDimune Inc. is a South Korean therapeutics company focused on developing innovative drug delivery systems. Founded in 2015 and based in Seoul, the company specializes in the creation of cancer therapeutics using immune cell-derived and stem cell-derived vesicles. Its research and development efforts encompass a range of therapeutic areas, including personalized cancer treatments, osteoarthritis, chronic obstructive pulmonary disease, and neurodegenerative disorders. MDimune's proprietary platform enables targeted delivery of drugs, allowing for the development of novel therapeutics that enhance treatment efficacy. The company provides its vesicle-based delivery solutions to biotech and pharmaceutical enterprises, thereby facilitating advanced therapeutic options for patients.

Huinno, Inc. is a healthcare technology company established in 2014 and headquartered in Boston, Massachusetts, with additional offices in New York and Seoul. The company specializes in developing advanced healthcare devices designed to monitor vital health data, including blood pressure, heart rate, electrocardiograms (ECG), and blood oxygen saturation levels. Utilizing proprietary wearable devices along with AI-based analytics, Huinno aims to transform the management of chronic cardiac diseases by providing continuous, real-time health monitoring with clinical-grade accuracy. Their platform includes an application and a cloud-based ecosystem that facilitates longitudinal trend analysis of patients' health metrics, medication compliance, and lifestyle habits. By offering healthcare providers a robust remote patient monitoring solution, Huinno enhances chronic disease prevention and reduces hospital readmission rates, ultimately supporting clinicians in making informed medical decisions.

StemLab Inc. is a Korean biotechnology company focused on developing innovative therapeutic solutions for diseases and injuries that lack effective treatments. The company specializes in cell therapy through its proprietary cell reprogramming technology, which transforms somatic cells into neural stem cells, facilitating the creation of stem cell therapies without the ethical concerns associated with embryonic stem cells. This technology allows StemLab to produce reprogrammed neural stem cells with expansion capabilities comparable to those derived from pluripotent sources, utilizing non-invasive methods by sourcing cells from urine. StemLab holds 18 patents for its original stem cell treatment technologies, along with additional patents for application technology, and has several pending. Its primary clinical programs target conditions such as spinal cord injury and Amyotrophic Lateral Sclerosis. Additionally, StemLab manufactures automated magnetic resonance imaging systems and other medical devices to support its therapeutic developments. The company is headquartered in Seoul, South Korea.

Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

CytoDx is a bio-venture company focused on advancing cancer diagnosis, prediction, and treatment through innovative technology. The company specializes in developing a liquid biopsy platform that isolates and cultures target cells from blood samples. By analyzing genetic material, including DNA from cancer cells found in body fluids such as blood or urine, CytoDx enables early detection of various cancers. Additionally, the company is working on an automated system for precise diagnosis and life cycle monitoring technology aimed at improving cancer management and overcoming challenges associated with the disease.

Tomocube Inc., founded in 2015 and headquartered in Daejeon, South Korea, specializes in the design and manufacture of advanced 3D optical microscopes. The company offers products such as the HT-1 and HT-2, which utilize holotomography to create detailed 3D images of biological samples, including red blood cells, sperm cells, and CAR-T cells. Unlike conventional microscopes that provide only 2D views, Tomocube's innovative technology allows researchers to observe living cells in real-time without the need for invasive sample preparation. By integrating deep learning-based image recognition, Tomocube's microscopes facilitate the dynamic observation of cells and tissues, thereby enhancing the understanding, diagnosis, and treatment of human diseases.

T&R Biofab, established in 2013 and headquartered in Siheung, South Korea, is a biotechnology company specializing in the development of medical devices for transplantation and tissue regeneration. The company focuses on orthopedics, plastic surgery, and dentistry, offering products such as craniomaxillofacial meshes, dental meshes, and patient-specific implants. T&R Biofab utilizes innovative 3D printing technology to manufacture bioresorbable scaffolds that aid in the regeneration and reconstruction of tissues and organs.

Jeisys Medical, established in 2001 and headquartered in Seoul, South Korea, specializes in designing, developing, and manufacturing medical devices for various healthcare professionals, including plastic surgeons, dermatologists, and physicians. The company's portfolio spans across multiple treatment areas such as fat reduction, skin tightening, rejuvenation, and removal of unwanted pigments, tattoos, and acne. Notable products include LIPOcel, ULTRAcel Q+, and AcGen, marketed under brands like LIPOcel, ULTRAcel, and AcGen. Jeisys Medical distributes its products globally through a network of distributors.

Genomictree, Inc. is a molecular diagnostics company focused on epigenomic biomarker-based technologies. The company develops innovative solutions aimed at addressing unmet needs within the healthcare market. By leveraging advancements in molecular diagnostics, Genomictree strives to enhance disease detection and management, ultimately improving patient outcomes.

Noul is a healthcare technology company that develops innovative diagnostic solutions to tackle chronic and systemic health issues globally. Its flagship product, miLab, is an automated device that combines sample preparation and artificial intelligence-based diagnostics into a single workflow, integrating computer vision AI, biotechnology, hardware, and software engineering. Noul aims to enhance human health by contributing to the eradication of infectious and non-infectious diseases.

ViGenCell is a medical company focused on developing immune cell therapy products. The company is dedicated to improving the quality of life and extending the life expectancy of patients with incurable diseases through its innovative therapies. By leveraging advanced technologies in immune cell manipulation and treatment, ViGenCell aims to provide effective solutions for challenging health conditions that currently lack adequate treatment options.

Genoplan is a company focused on democratizing healthcare through the application of population genomics and advanced analytics. It provides a personal genetic testing solution that includes a DNA testing kit for analyzing users' saliva. This analysis generates comprehensive reports that offer insights into genetic predispositions, enabling individuals to make informed lifestyle choices regarding diet, fitness, and personal care. By making genomics more accessible, Genoplan aims to foster a deeper understanding of personal health and contribute to the evolution of precision medicine, ultimately empowering individuals to take charge of their well-being.

SCM Lifescience, founded in 2014, focuses on the research and development of innovative treatment options for challenging diseases. The company utilizes proprietary technologies for stem cell isolation and production, aiming to create new therapies that offer hope to patients and contribute to overall human welfare. Based in South Korea, SCM Lifescience is also involved in developing medicinal products and hair care solutions, leveraging its expertise in stem cell applications to address various health-related needs.

CareLabs Company is an Ireland-based digital beauty and healthcare firm that specializes in providing accessible medical services and reliable healthcare information. The company offers a range of healthcare information technology services, including clinic management software and digital marketing solutions. CareLabs operates a healthcare media platform that features GoodDak, a mobile service for medical information, and Barbietk, which focuses on sharing reviews related to cosmetics, skincare, and diet. Through these services, CareLabs aims to enhance the accessibility and quality of healthcare information for users.

Ensol Biosciences Inc. is a biopharmaceutical company based in Daejeon, South Korea, specializing in the development of innovative therapies for serious conditions with limited treatment options, including degenerative disc disease, osteoarthritis, various cancers, Alzheimer's dementia, and type 1 diabetes. The company's drug pipeline features several candidates in clinical trials, such as Peniel 2000 for degenerative disc disease and Engedi 1000 for osteoarthritis. Additionally, it is advancing treatments like Charis 1000 for triple negative breast cancer and Moriah 1000 for Alzheimer's disease. Ensol Biosciences also provides contract drug development services, encompassing chemistry, manufacturing, and controls, alongside its Knowledge-based In Silico Drug Discovery platform for identifying new therapeutic candidates. Founded in 2001 and previously known as Ensoltek Co., Ltd., Ensol Biosciences is committed to addressing unmet medical needs through its research and development initiatives.

3D MediVision, Inc. is a South Korean company that specializes in the development and manufacturing of 3D visualization and live-casting systems tailored for surgeries. Established in 2011 and headquartered in Seoul, the company offers a range of products including 3D/2D cameras, recorders, monitors, and ultrasound systems. Its innovative technology allows surgeons to capture and share surgical procedures in 3D, enhancing the educational experience for medical professionals. The company also provides SURGFLIX, a platform for sharing 2D and 3D surgical content, and VeterFlix, which focuses on surgical training for veterinarians. 3D MediVision's products are distributed through authorized partners across various countries, including India, Spain, Mexico, and China, facilitating access to high-quality surgical visualization tools for healthcare providers globally.

Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a bispecific antibody platform technology known as AliCE, which maintains the structural integrity of the parental antibody, ensuring high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL, a unique library of human antibodies, which supports its research and development efforts. The company is recognized for its contributions to the global immuno-chemotherapeutic drug market and also offers contract research services, aiming to advance its position within the biotechnology sector.

WSG is a manufacturer and supplier specializing in precision-engineered flow components designed for ultra-high-purity applications. The company develops automated and fully integrated welded tube production systems, serving a diverse range of sectors including semiconductors, LCD/OLED displays, microelectronics, biotechnology, life sciences, and pharmaceuticals. WSG focuses on providing clients with vertically integrated manufacturing solutions, emphasizing cost efficiency and high precision in its offerings.

Celemedi is a technology-based drug development company that develops immune anti-cancer drugs.

Cellid, Inc. is a bioventure company based in Seoul, South Korea, focused on the research and development of immunotherapeutic vaccines for cancer and infectious diseases. The company is advancing several vaccine candidates, including BVAC-C for cervical, head and neck cancers associated with human papilloma virus, BVAC-B for gastric, ovarian, lung, and pancreatic cancers targeting the HER-2/neu antigen, and BVAC-P for prostate and urinary tract cancers utilizing PAP/PSMA antigens. Additionally, Cellid is developing BVAC-M for melanoma and BVAC-Neo, a customized immunotherapeutic vaccine designed from a patient's own cells. Founded in 2006, Cellid aims to create personalized treatment options that leverage the patient's immune system to combat various types of cancer.

Mediogen is a life science company focused on the research and development of probiotic medicinal products. It specializes in supplying probiotic raw materials for use in functional foods, general food products, and cosmetics. Utilizing patented coating technology, Mediogen aims to enhance the effectiveness of its probiotics, thereby promoting healthier lifestyles for consumers. The company's commitment to innovation in the probiotic sector positions it as a significant player in the life sciences industry.

Live Cell Instrument specializes in the development and manufacturing of advanced imaging systems and microscopes, along with a range of scientific instruments and laboratory consumables. The company's product lineup includes automated imaging systems, microscope incubators, magnetic imaging chambers, heating systems, and LED excitation systems. These offerings are designed to support the bio-industry by providing modern tools for research, enhancing the capabilities of scientists and researchers in their work.

42Maru, Inc. is a South Korean technology company established in 2015, specializing in the development of advanced search engine technology designed for artificial intelligence applications. The firm focuses on creating a deep learning-based question-answering system that accurately interprets user intent and provides precise answers in real-time. Its technology encompasses various domains, including information retrieval, machine reading comprehension, and natural language processing, making it applicable across multiple sectors such as smart speakers, connected cars, chatbots, and home automation devices. 42Maru stands out in the market due to its high accuracy, efficient knowledge base expansion, and low operational costs. The company aims to penetrate the consumer market through strategic B2B2C alliances while supporting multiple languages for global expansion. With a team of experts led by a CEO with over 20 years of industry experience, 42Maru has formed partnerships with major telecommunications companies and financial institutions, positioning itself at the forefront of the emerging AI-driven search paradigm.

CURAUM Inc. is a South Korean company focused on developing and selling innovative oral care and sleep-related health care products. Founded in 2017 and headquartered in Yuseong, South Korea, with additional offices in Seoul, Incheon, and Newport Beach, California, CURAUM offers a range of devices aimed at enhancing oral hygiene and managing sleep disorders. Their product line includes the Clium Cleaner, designed specifically for cleaning and sterilizing dental devices; the Clium S-Guard, an omnidirectional device that addresses obstructive sleep apnea and snoring; and the Clium System, which provides personalized management for chronic sleep disorders through a home health care platform. CURAUM also employs technology to collect and analyze users' health data, enabling the monitoring of hygiene status and early diagnosis of potential health issues, thereby promoting healthier habits and preventive care.

Tiernes is a dental practice that focuses on digital, clear orthodontic treatments. It operates a digital dentistry platform, offering a range of products such as aligner systems, orthodontic mini screws, and other instruments designed to make dental procedures more comfortable for patients.

NeuroXT is a technology company specializing in the development of software products for precision diagnosis in healthcare. Their primary offerings include NEXT-ATN, NEXT-ALZ-CDx, and NEXT-S, which use magnetic resonance imaging (MRI) to analyze and predict molecular pathology values. This enables healthcare professionals to determine the suitability of specific treatments or drugs for patients with degenerative brain diseases, thereby enhancing precision and personalization in care.